Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy Subjects
Clinical trial NCT01878474 · COMPLETED
Trial details
- NCT number
- NCT01878474
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2009-06-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.